news New headquarters in Scotland strengthens drug discovery research 10 August 2017 | By Dr Zara Kassam (Drug Target Review) A provider of products and services for research in stem cells, drug discovery, human tissues and 3D cell culture has opened its European headquarters in Glasgow, UK...
news Prospects identified for immunotherapy treatments 9 August 2017 | By Dr Zara Kassam (Drug Target Review) A report published has identified the prospects of immunotherapy treatments...
news Promising therapeutic approach for improving mitochondrial function 9 August 2017 | By Dr Zara Kassam (Drug Target Review) Scientists have made progress in the development of products that improve mitochondrial function...
news New antibiotic class found effective against gonorrhoea 7 August 2017 | By Dr Zara Kassam (Drug Target Review) Researchers have tested samples of N. gonorrhoeae from patients with infections in the throat, urethra, cervix and rectum, they found that at very low amounts closthioamide was effective...
news ERC invest nearly €2bn in European researchers 4 August 2017 | By Dr Zara Kassam (Drug Target Review) The European Research Council has announced its 2018 grant competitions with a total budget of around €1.86bn...
news Orphan drug market to double as Pharma rethinks business model 21 July 2017 | By Steve Bremer (Drug Target Review) Market intelligence suggests pharma is being forced to shift focus towards niche patient populations and orphan diseases ...
news Takeda launches contract R&D firm AXCELEAD 20 July 2017 | By Steve Bremer (Drug Target Review) Takeda has launched a contract research and development company, AXCELEAD, at its Shonan Research Centre.
news Feinstein Institute identifies potential cause for lupus 18 July 2017 | By Sarah Wills (Drug Target Review) A protein has been identified as a possible cause for the adverse reaction of the immune system in patients suffering from lupus.
news DFG approves 7 new research units and a new clinical research unit 14 July 2017 | By Niamh Marriott (Drug Target Review) Topics range from planet formation and male infertility to market analysis for agricultural land and total of around €19 million for first funding period…
news Lymph node metastases may not always be source of cancer’s spread 7 July 2017 | By Niamh Marriott (Drug Target Review) A study led has found that the model for the spread of carcinoma - from the primary tumour, to nearby lymph nodes, to other organs - may not apply in all cases.
news New study links antibiotic resistance to common household disinfectant 6 July 2017 | By Niamh Marriott (Drug Target Review) Scientists have discovered a link between a major mechanism of antibiotic resistance and resistance to the common disinfectant triclosan...
news Study asks if mistaken antibodies led research down 20-year dead end 3 July 2017 | By Niamh Marriott (Drug Target Review) For nearly two decades researchers have sought a way to target an oestrogen receptor in the hope they could improve breast cancer survival, but an article contends that the effort may never pan out.
webinar High performance computing for high content screening – A case study 30 June 2017 | By PerkinElmer In this webinar, PerkinElmer and AMRI will present a case study wherein high-performance computing (HPC) was leveraged for enhanced performance in image and data analysis of High Content Screening experiments...
news Drug developed for arthritis could be first to stop heart valve calcification 16 June 2017 | By Niamh Marriott (Drug Target Review) The first drug to treat calcification of heart valves may be one originally designed for rheumatoid arthritis.
news New leukaemia treatment outperforms standard chemotherapies 9 June 2017 | By Niamh Marriott (Drug Target Review) Researchers at The Australian National University (ANU) are working on a new treatment for an aggressive type of leukaemia that outperforms standard chemotherapies.
